Company news
TME Pharma N.V. news in 2026
TME Pharma N.V.'s news releases, calls and decks from 2026, newest first.
TME Pharma Publishes Its Semi Annual Results and Half-Year Report
October 29, 2026
TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd.
October 28, 2026
TME Pharma extends financial visibility by lengthening debt maturity to June 2028
October 25, 2026
TME Pharma CEO message
September 16, 2026
Message du CEO de TME Pharma
September 15, 2026
TME Pharma fait le point sur ses activités
August 23, 2026
Minutes of the TME Pharma Annual General Meeting
June 17, 2026
Compte-rendu de l’assemblée générale de TME Pharma
June 16, 2026
TME Pharma announces convocation of the 2026 annual general meeting of shareholders
May 21, 2026
TME Pharma publishes its annual financial results and annual report
April 30, 2026
TME Pharma Announces Publication of NOX-A12 “Triple Therapy” Phase 1/2 Expansion Arm A Findings from GLORIA trial in Nature Communications
April 16, 2026
TME Pharma extends financial runway to over 12 months
March 9, 2026
TME Pharma provides update on its activities
January 5, 2026